ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0538

Development of an Artificial Intelligence Tool for Lesion Detection in Axial Spondyloarthritis patients with Active Sacroiliitis on Magnetic Resonance Imaging

Khalid Alnaqbi1, Jorge Juan Fragío Gil2, Hiba Khogali3, Gianina Statache4, Alzahraa Abouelnadar4, Ahlam Almarzooqi5, Amina AlJasmi6, Jameel Shawaqfeh7, Manal Mashaleh8, Maysoon Bani Hani7, Saitah Alshammari9, Yasser H. Alghamdi9, Faisal Alfaisal9, Abdulaziz Almosabihi9, Cristina Campos Fernández10, Roxana González Mazario10, Jose Lozano-Montoya11, Ana Jiménez-Pastor11, Paula Moreno-Ruiz11, Marta Martínez-Calle11, Fuensanta bellvís-Bataller11 and Almudena Fuster-Matanzo11, 1Sheikh Tahnoon Medical city, Al Ain, United Arab Emirates, 2Hospital General Universitario, Valencia, Spain, 3Madinat Zayed Hospital , Al Dhafra hospitals, Abu Dhabi, Abu Dhabi, United Arab Emirates, 4Abu Dhabi Stem Cell Centre/Yas Clinic Hospital, Abu Dhabi, United Arab Emirates, 5Emirates Health Services, Sharjah, United Arab Emirates, 6Emirates Health Services, Dubai, United Arab Emirates, 7Royal Medical Services, Amman, Jordan, 8Al Saudi Hospital, Amman, Jordan, 9King Saud Medical City, Riyadh, Saudi Arabia, 10Hospital General de Valencia, Valencia, Spain, 11Quibim, Valencia, Spain

Meeting: ACR Convergence 2025

Keywords: Magnetic resonance imaging (MRI), spondyloarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 26, 2025

Title: (0522–0553) Spondyloarthritis Including Psoriatic Arthritis – Diagnosis, Manifestations, & Outcomes Poster I

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: Axial spondyloarthritis (axSpA) is a chronic immune-mediated inflammatory disease primarily affecting spine and sacroiliac joints (SIJ), leading to pain and disability. Magnetic resonance imaging (MRI) has transformed axSpA diagnosis in non-radiographic cases–undetectable on X-rays–, guiding treatment and improving long term outcomes. As per the Assessment of Spondyloarthritis international Society (ASAS), “active sacroiliitis” requires bone marrow edema (BME) on T2-weighted MRI, indicating SIJ inflammation highly suggestive of axSpA. However, “positive MRI” definitions vary, with high inter-/intra-observer variability and frequent underdiagnosis, contributing to a mean 7-year delay. Thus, standardized, automated tools are needed. This study aimed to develop an artificial intelligence (AI)-based model to detect active axSpA on MRI.

Methods: This retrospective, observational study (NCT06591481) used real-world data from six international sites. The dataset included 684 SIJ MRIs, each with coronal-oblique T2 short tau inversion recovery (STIR) or T2 fat-saturated (FS) sequences acquired at diagnosis and follow-up. Imaging data were collected and processed using Quibim platform (Quibim SL, Valencia, Spain). All scans underwent quality checks by three radiographers with >5 years of experience on image interpretation. Following ASAS criteria, MRIs were double read by radiologists with >12 years of experience, with adjudication by a third reader. Scans were classified as positive active sacroiliitis on MRI (ASAS-positive MRI; BME on two consecutive slices) or negative, and structural damage (ankylosis, erosion and fat metaplasia) were noted. A deep-learning-based AI classification model was developed to identify axSpA patients with ASAS-positive MRI. Of the total 684 cases, 563 were used for training and validation, and 121 for testing. The model performs automated sacroiliac joint segmentation on T2 imaging to predict BME presence across patient slices. Detection of two consecutive positive slices yields a positive patient diagnosis. To enhance interpretability, heat maps highlight the regions that most influence the model’s predictions.

Results: Overall, 32% of patients (n = 218) fulfilled the ASAS classification criteria for axSpA. The model achieved high balanced accuracy (bal acc = 81.3%), sensitivity (se = 71.4%) and specificity (sp = 91.1%) for ASAS-positive MRI detection. Performance was higher (bal acc = 89.3%; se = 84% and spe = 94.5%) in cases with consensus readings and clearly visible lesions on at least two consecutive slices. However, performance declined (bal acc = 51.5%) in cases with poor image quality, motion artifacts, or subtle lesions, highlighting the need for expert oversight. In such cases heat maps can assist in achieving a correct diagnosis.

Conclusion: We developed an AI-based classification model with high diagnostic performance in detecting MRI-positive axSpA, especially in terms of specificity (91.1%). This tool could support radiologists by standardizing MRI interpretation. Its integration into clinical workflows may enhance diagnostic accuracy and improve patient care.

Supporting image 1Figure 1. Development of AI-based tool for lesion detection in axSpA patients with active sacroiliitis using MRI


Disclosures: K. Alnaqbi: None; J. Fragío Gil: Quibim, 1; H. Khogali: None; G. Statache: None; A. Abouelnadar: None; A. Almarzooqi: None; A. AlJasmi: None; J. Shawaqfeh: None; M. Mashaleh: None; M. Bani Hani: None; S. Alshammari: None; Y. Alghamdi: None; F. Alfaisal: None; A. Almosabihi: None; C. Campos Fernández: Hospital General Universitario, 2; R. González Mazario: None; J. Lozano-Montoya: Quibim, 3; A. Jiménez-Pastor: Quibim, 3; P. Moreno-Ruiz: Quibim, 3; M. Martínez-Calle: Quibim, 3; F. bellvís-Bataller: Quibim, 3; A. Fuster-Matanzo: Quibim, 3.

To cite this abstract in AMA style:

Alnaqbi K, Fragío Gil J, Khogali H, Statache G, Abouelnadar A, Almarzooqi A, AlJasmi A, Shawaqfeh J, Mashaleh M, Bani Hani M, Alshammari S, Alghamdi Y, Alfaisal F, Almosabihi A, Campos Fernández C, González Mazario R, Lozano-Montoya J, Jiménez-Pastor A, Moreno-Ruiz P, Martínez-Calle M, bellvís-Bataller F, Fuster-Matanzo A. Development of an Artificial Intelligence Tool for Lesion Detection in Axial Spondyloarthritis patients with Active Sacroiliitis on Magnetic Resonance Imaging [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/development-of-an-artificial-intelligence-tool-for-lesion-detection-in-axial-spondyloarthritis-patients-with-active-sacroiliitis-on-magnetic-resonance-imaging/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/development-of-an-artificial-intelligence-tool-for-lesion-detection-in-axial-spondyloarthritis-patients-with-active-sacroiliitis-on-magnetic-resonance-imaging/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology